What is he best known for?
The fields of study he is best known for:
- Gene
- Immune system
- Cytokine
His primary scientific interests are in Immunology, Chemokine, Cell biology, Immune system and Chemokine receptor.
Inflammation, Cytokine, Innate immune system, CD8 and CXCL10 are the core of his Immunology study.
His research in Chemokine intersects with topics in Proinflammatory cytokine, Molecular biology, Cytotoxic T cell and Chemotaxis.
His Cell biology study combines topics from a wide range of disciplines, such as Toll-like receptor, Senile plaques, Microglia, Cell adhesion and Interleukin 4.
His Immune system study incorporates themes from Cell, Autoimmune disease, Autoantibody and Systemic lupus erythematosus.
Andrew D. Luster studied CXCR3 and CXCL9 that intersect with CXCL11.
His most cited work include:
- Chemokines — Chemotactic Cytokines That Mediate Inflammation (3232 citations)
- MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. (1088 citations)
- Chemokines and Chemokine Receptors: Positioning Cells for Host Defense and Immunity (967 citations)
What are the main themes of his work throughout his whole career to date?
Andrew D. Luster focuses on Immunology, Chemokine, Cell biology, Immune system and Inflammation.
His Immunology study frequently links to other fields, such as Receptor.
His study in Chemokine is interdisciplinary in nature, drawing from both Molecular biology and Chemotaxis.
His Immune system research includes themes of Cell and Virology.
The concepts of his Inflammation study are interwoven with issues in Asthma and Lung.
His CXCR3 study combines topics in areas such as CD8 and CXC chemokine receptors.
He most often published in these fields:
- Immunology (62.00%)
- Chemokine (39.43%)
- Cell biology (20.19%)
What were the highlights of his more recent work (between 2014-2021)?
- Immunology (62.00%)
- Chemokine (39.43%)
- Immune system (18.05%)
In recent papers he was focusing on the following fields of study:
His main research concerns Immunology, Chemokine, Immune system, Inflammation and Chemokine receptor.
His work on Immunology deals in particular with Innate immune system, Acquired immune system, Immunity, Arthritis and Allergen.
His research integrates issues of T cell, Pharmacology and Cell biology in his study of Chemokine.
His work carried out in the field of Immune system brings together such families of science as Stromal cell, Cytokine, Pathogenesis and Virology.
His research investigates the connection between Inflammation and topics such as Asthma that intersect with issues in Lung.
His work deals with themes such as Epitope, Proinflammatory cytokine, Signal transduction and Blocking antibody, which intersect with Chemokine receptor.
Between 2014 and 2021, his most popular works were:
- The Chemokine System in Innate Immunity (240 citations)
- Non-redundant requirement for CXCR3 signalling during tumoricidal T-cell trafficking across tumour vascular checkpoints (216 citations)
- Single-Cell RNA Sequencing of Lymph Node Stromal Cells Reveals Niche-Associated Heterogeneity (142 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Immune system
- Cytokine
Andrew D. Luster spends much of his time researching Immunology, Chemokine, Immune system, Cell biology and CD8.
His research in the fields of Inflammation and Immunity overlaps with other disciplines such as Population.
Andrew D. Luster does research in Chemokine, focusing on Chemokine receptor specifically.
His Immune system research focuses on Virology and how it relates to Hematopoietic stem cell transplantation, Nod, Myeloid, Acquired immunodeficiency syndrome and Human leukocyte antigen.
His Cell biology research includes elements of Stromal cell, CCL21, Connective tissue, Lymph node and C-C chemokine receptor type 7.
Andrew D. Luster interconnects Cancer research, Spleen, Cytotoxic T cell, CXCR3 and Immunotherapy in the investigation of issues within CD8.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
